19:50 EST Aptose Biosciences (APTO) trading halted, news pending
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on APTO:
- Upcoming Stock Splits This Week (February 24 to February 28) – Stay Invested
- Aptose Biosciences Advances TUSCANY Trial Dosage Escalation
- Aptose Biosciences approved to escalate dose in Phase 1/2 AML trial
- Aptose Biosciences Announces Reverse Share Split
- Aptose Biosciences announces 1-for-30 reverse share split